Sep . 10, 2025 03:35 Back to list

Low GI70 Soba-Diabetic Noodles|Low GI, Patented Technology



For individuals managing diabetes or seeking to maintain stable blood sugar levels, Low GI70 Soba represents a groundbreaking innovation in functional food. Developed by Hebei Jinxu Noodles Co., Ltd., this product combines advanced nutritional science with traditional dietary principles to deliver a low glycemic index (GI) noodle that supports metabolic health. Below, we explore its unique features, scientific validation, and broader implications for health-conscious consumers.

Product Overview

Low GI70 Soba is a specially formulated noodle product designed to address the dietary needs of individuals with diabetes, pre-diabetes, and those prioritizing blood sugar control. Its core innovation lies in its patented surface technology, which incorporates 70% buckwheat, konjac, and green barley, along with tartary buckwheat. These ingredients are carefully selected for their low glycemic impact and high nutritional value.

Low GI70 Soba-Diabetic Noodles|Low GI, Patented Technology Low GI70 Soba-Diabetic Noodles|Low GI, Patented Technology Low GI70 Soba-Diabetic Noodles|Low GI, Patented Technology

Key Features and Advantages

The product's unique formulation offers multiple benefits, including:

  • Low Glycemic Index: With a GI value of 42.7, Low GI70 Soba is certified as a low GI food by the Beijing Institute of Nutrition Source. This ensures minimal spikes in blood glucose levels after consumption.
  • High Dietary Fiber: The inclusion of konjac and tartary buckwheat provides exceptional satiety, making it an ideal choice for weight management and reducing overall calorie intake.
  • Patented Technology: The national invention patent technology blocks sugar sources, effectively reducing the glycemic response while maintaining the noodle's texture and flavor.
  • Nutrient-Rich: Packed with essential vitamins, minerals, and antioxidants from its natural ingredients, it supports overall health without compromising on taste.

Clinical and Scientific Validation

Low GI70 Soba's efficacy is backed by rigorous scientific research and clinical trials. Notably, it has undergone a three-month clinical study at Shanxi Medical University, where it demonstrated significant stabilization of blood sugar levels in diabetic participants. The results, published in a peer-reviewed journal, highlight its potential as a complementary dietary intervention for diabetes management.

Low GI70 Soba-Diabetic Noodles|Low GI, Patented Technology Low GI70 Soba-Diabetic Noodles|Low GI, Patented Technology

Additionally, a one-year community-based tasting program involving individuals with high blood sugar levels confirmed its long-term effectiveness in lowering glucose levels. These trials were conducted in collaboration with community healthcare professionals, ensuring adherence to medical standards.

Technical Specifications

Specification Details
Product Name Low GI70 Soba
Weight 300g
GI Value 42.7 (Low GI)
Shelf Life 4 months at room temperature, 8 months refrigerated
Storage Conditions Cool, dry place or 0-10°C refrigeration
Ingredients 70% buckwheat, konjac, green barley, tartary buckwheat
Certifications Low GI Food Certification, National Invention Patent

Target Consumers

Low GI70 Soba is designed for a diverse range of consumers, including:

  • Diabetic Patients: Its low GI and patented technology make it a safe and effective dietary option for managing blood sugar levels.
  • Individuals with Metabolic Syndrome: Those with "three highs" (hypertension, hyperlipidemia, and hyperglycemia) can benefit from its nutrient profile and glycemic control properties.
  • Health-Conscious Consumers: People seeking to reduce sugar intake or improve dietary fiber consumption will find this product appealing.
  • Sub-Healthy Individuals: The product's rich nutritional content supports overall well-being and energy balance.

Company Background: Hebei Jinxu Noodles Co., Ltd.

Founded in 2015, Hebei Jinxu Noodles Co., Ltd. has established itself as a leader in the production of functional food products. The company's commitment to innovation is evident in its investment in R&D and partnerships with academic institutions. By integrating traditional Chinese dietary principles with modern nutritional science, Hebei Jinxu has developed a product line that addresses contemporary health challenges.

As a certified manufacturer, the company adheres to stringent quality control standards. Its products undergo regular inspections by authoritative bodies, including the Beijing Institute of Nutrition Source, ensuring compliance with national food safety regulations.

Conclusion

Low GI70 Soba exemplifies the potential of functional foods to transform dietary management for individuals with chronic conditions. By combining scientific innovation with natural ingredients, this product offers a practical solution for maintaining metabolic health. Its clinical validation, nutritional benefits, and user-friendly design position it as a valuable addition to any health-conscious diet.

For more information, visit Low GI70 Soba's official page or explore the Hebei Jinxu Noodles Co., Ltd. website to learn about their other products and mission.

References

NIST (National Institute of Standards and Technology). (n.d.). https://www.nist.gov. Retrieved from https://www.nist.gov

Beijing Institute of Nutrition Source. (n.d.). Low GI Food Certification. Retrieved from [Internal Documentation].

Shanxi Medical University. (2024). Clinical Trial Results on Low GI70 Soba. Retrieved from [Internal Reports].

Low GI70 Soba-Diabetic Noodles|Low GI, Patented Technology Low GI70 Soba-Diabetic Noodles|Low GI, Patented Technology Low GI70 Soba-Diabetic Noodles|Low GI, Patented Technology

Share

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.